Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle‐aged individuals with metabolic dysfunction

(2023) Alessandro Mantovani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

(2023) Chiara Rosso et al.   Clinical Gastroenterology and Hepatology

Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction

(2023) Melissa Tomasi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Rare ATG7 genetic variants predispose patients to severe fatty liver disease

(2022) Guido A. Baselli et al.   JOURNAL OF HEPATOLOGY

Sex bias in clinical trials in gastroenterology and hepatology

(2022) Patrizia Burra et al.   Nature Reviews Gastroenterology & Hepatology

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

(2022) Frauke Degenhardt et al.   HUMAN MOLECULAR GENETICS

ERα-Dependent Regulation of Adropin Predicts Sex Differences in Liver Homeostasis during High-Fat Diet

(2022) Clara Meda et al.   Nutrients

Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH

(2022) Darren Jun Hao Tan et al.   HEPATOLOGY

Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease

(2021) Oveis Jamialahmadi et al.   GASTROENTEROLOGY

Population attributable risk of cirrhosis and hepatocellular carcinoma due to genetic predisposition to fatty liver disease

(2021) Oveis Jamialahmadi et al.   JOURNAL OF HEPATOLOGY

Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)

(2021) Patrizia Burra et al.   LIVER INTERNATIONAL

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity

(2021) Marco Arrese et al.   SEMINARS IN LIVER DISEASE

PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date

(2021) Alessandro Cherubini et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α

(2021) Sara Della Torre et al.   Nature Communications

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

(2020) Guido Alessandro Baselli et al.   GUT

Update on NAFLD genetics: from new variants to the clinic

(2020) Eric Trépo et al.   JOURNAL OF HEPATOLOGY

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes

(2020) Marica Meroni et al.   EBioMedicine

STAT3: A key regulator in liver fibrosis

(2020) Jie Zhao et al.   Annals of Hepatology

The association of sex steroid hormone concentrations with non‐alcoholic fatty liver disease and liver enzymes in US men

(2020) Hong Phan et al.   LIVER INTERNATIONAL

Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease

(2019) Kuei-Chuan Lee et al.   LABORATORY INVESTIGATION

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

(2019) S. Pelusi et al.   Clinical Gastroenterology and Hepatology

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

(2019) Piero Pingitore et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis

(2019) Soumik BasuRay et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

(2019) Daniel Lindén et al.   Molecular Metabolism

Genetic factors, adherence to healthy lifestyle behavior, and risk of invasive breast cancer among women in the UK Biobank

(2019) Rhonda S Arthur et al.   JNCI-Journal of the National Cancer Institute

Hepatic ERα accounts for sex differences in the ability to cope with an excess of dietary lipids

(2019) Clara Meda et al.   Molecular Metabolism

The UK Biobank resource with deep phenotyping and genomic data

(2018) Clare Bycroft et al.   NATURE

The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells

(2017) Francesca Virginia Bruschi et al.   HEPATOLOGY

The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation

(2017) Soumik BasuRay et al.   HEPATOLOGY

Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci

(2017) Stefan Stender et al.   NATURE GENETICS

Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in males

(2017) Shuiqing Qiu et al.   Scientific Reports

MultiQC: summarize analysis results for multiple tools and samples in a single report

(2016) Philip Ewels et al.   BIOINFORMATICS

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

(2016) Rosellina Margherita Mancina et al.   GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive Cycle

(2016) Sara Della Torre et al.   Cell Reports

Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver

(2015) Meritxell Huch et al.   CELL

Estrogen receptors regulate innate immune cells and signaling pathways

(2015) Susan Kovats   CELLULAR IMMUNOLOGY

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

(2015) Paola Dongiovanni et al.   HEPATOLOGY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

(2015) Stephan Buch et al.   NATURE GENETICS

Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis

(2015) Minqian Shen et al.   International Journal of Endocrinology

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Pnpla3I148Mknockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

(2014) Eriks Smagris et al.   HEPATOLOGY

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

(2014) Carlo Pirazzi et al.   HUMAN MOLECULAR GENETICS

Estrogen biology: New insights into GPER function and clinical opportunities

(2014) Eric R. Prossnitz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects

(2014) Bin Shen et al.   NATURE METHODS

Estrogen synthesis and signaling pathways during aging: from periphery to brain

(2013) Jie Cui et al.   TRENDS IN MOLECULAR MEDICINE

Isolating lipid droplets from multiple species

(2012) Yunfeng Ding et al.   Nature Protocols

Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes

(2012) Yasumasa Ikeda et al.   PLoS One

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

(2011) Bo Li et al.   BMC BIOINFORMATICS

Amino Acid-Dependent Activation of Liver Estrogen Receptor Alpha Integrates Metabolic and Reproductive Functions via IGF-1

(2011) Sara Della Torre et al.   Cell Metabolism

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

(2011) Silvia Sookoian et al.   HEPATOLOGY

Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats

(2010) Russell T. Turner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity

(2009) Silvia Sookoian et al.   JOURNAL OF LIPID RESEARCH

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS